ScreenerHero

DHR Danaher Corporation

NYSE · US · Healthcare · Diagnostics & Research · danaher.com
217.15USD-1.84%Mkt Cap: 155.51B $P/E: 39.43

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, L…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$250.23BUSDP/E 36.4
NTRA
Natera, Inc.
$61.35BUSD
LONN
Lonza Group AG
$45.93BUSDP/E 38.2
A
Agilent Technologies, Inc.
$48.29BUSDP/E 33.8
ILMN
Illumina, Inc.
$44.35BUSDP/E 54.8
IQV
IQVIA Holdings Inc.
$43.80BUSDP/E 33.1
WAT
Waters Corporation
$43.21BUSDP/E 111.4
IDXX
IDEXX Laboratories, Inc.
$41.58BUSDP/E 37.0
MTD
Mettler-Toledo International Inc.
$30.89BUSDP/E 34.7
DGX
Quest Diagnostics Incorporated
$25.63BUSDP/E 24.7
GH
Guardant Health, Inc.
$25.12BUSD
LH
Labcorp Holdings Inc.
$25.03BUSDP/E 25.5
RVTY
Revvity, Inc.
$17.56BUSDP/E 75.3
MEDP
Medpace Holdings, Inc.
$17.32BUSDP/E 36.4
CRL
Charles River Laboratories International, Inc.
$14.84BUSD
ERF
Eurofins Scientific SE
$14.16BUSDP/E 26.4
ICLR
ICON Public Limited Company
$12.99BUSDP/E 177.2
BIM
bioMérieux S.A.
$10.27BUSDP/E 20.5
QGEN
Qiagen N.V.
$9.46BUSDP/E 23.2
GRAL
GRAIL, Inc.
$6.88BUSD

Key Statistics

Company
Market Cap155.51B USD
Enterprise Value174.00B USD
Revenue (TTM)25.11B USD
Gross Profit14.52B USD
Net Income (TTM)3.61B USD
Revenue/Share35.47 USD
Last Price217.15 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees58.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)39.43
P/E (Forward)23.01
PEG1.28
EV/EBITDA21.67
EV/Revenue6.93
P/S5.99
P/B2.86
EPS (TTM)5.61
EPS (Forward)9.30
52W Range
160.9369% of range242.80
52W High242.80 USD
52W Low160.93 USD
Profitability
Gross Margin59.11%
Oper. Margin19.78%
EBITDA Margin31.97%
Profit Margin14.71%
ROE6.88%
ROA4.33%
Growth
Revenue Growth5.50%
Earnings Growth59.70%
Cash Flow & Leverage
Operating CF6.42B USD
CapEx (TTM)1.16B USD
FCF Margin17.23%
FCF Yield2.78%
Net Debt23.51B USD
Net Debt/EBITDA2.93
Balance Sheet
Debt/Equity0.37
Current Ratio1.65
Quick Ratio1.15
Book Value/Sh74.81 USD
Cash/Share6.18 USD
Dividends
Fwd Div Rate1.60 USD
Trail. Div Rate1.44 USD
Div. Yield0.75%
5Y Avg Yield0.43%
Payout Ratio25.67%
Ex-Div DateSep 30, 2026
Pay DateOct 30, 2026
Splits
Last Split1128:1000
Split DateOct 2, 2023
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)234.73 USD
Upside (mean)+8.1%
Target Range200.00 USD – 310.00 USD
200.00+8.1% to mean310.00
# Analysts22
Ownership
Shares Out.702.99M
Float625.87M
Insiders10.96%
Institutions84.35%
Short Interest
Short Ratio2.6d
Short % Float1.33%
Short % Out.1.19%
Shares Short8.34M
Short (prev mo.)8.78M
Technical
SMA 50208.79 (+4.0%)
SMA 200201.60 (+7.7%)
Beta0.81
S&P 52W Chg14.58%
Avg Vol (30d)3.72M
Avg Vol (10d)4.68M
Technical Indicators
RSI (14)57.5
MACD3.3849
MACD Signal3.6687
MACD Hist.-0.2838
BB Upper231.87 USD
BB Middle214.26 USD
BB Lower196.65 USD
BB Width16.44%
ATR (14)6.115 USD
Vol Ratio (20d)0.72x